CME Group (CME) Stock Forecast & Price Target

CME Group is benefiting from a durable exchange franchise that continues to convert rising market activity into higher earnings, with 3Q26 adjusted EPS of $3.02 above estimates, record revenues of $1.74B, and market data fees up 20% YoY, underscoring the power of its recurring, high-margin revenue streams. Its outlook is further strengthened by ADV growth of 16% YoY, open interest of 128 million contracts, and management’s confidence that recent pricing changes can lift transaction revenue by 0.5%-1.0%, while stock repurchases of $524M in 3Q26 support shareholder returns. Longer term, the company’s 27% stake in S&P Dow Jones Indices, exclusive S&P futures venue status, and expansion through NEX into cash FX, fixed income, and collateral optimization add diversification, while new products such as compute futures, 24/7 trading, and single-stock futures create additional growth vectors.

CME Group is vulnerable to slowing Average Daily Volume and weaker Revenue per Contract, which could pressure revenue and margins even though its franchise benefits from dominant positions in interest rates, equity indexes, foreign exchange, energy, metals, and commodities. Competition is a major concern, as FMX could take share in interest rate futures, CBOE may divert flow into equity index volatility products, and ICE continues to challenge energy futures and options market share. The company also faces macro headwinds from lower interest rate cycles, widening credit spreads, and a less favorable yield-curve backdrop, while poor deal integration or adverse regulatory changes could further damage quarterly and FY operating performance.